Is EIGR or RYLD a better dividend investment in 2026?

EIGR currently yields 115.94% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: EIGR offers higher current income.

What is the dividend yield difference between EIGR and RYLD?

EIGR has a forward dividend yield of 115.94% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 103.55 percentage points.

Home › Compare › EIGR vs RYLD

EIGR vs RYLD: Dividend Comparison 2026

EIGR yields 115.94% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EIGR wins by $7.28M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EIGR

● Live price

115.94%

Share price

$1.73

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.32M

Annual income

$2,715,715.87

Full EIGR calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — EIGR vs RYLD

📍 EIGR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EIGR	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EIGR + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EIGR pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EIGR

Annual income on $10K today (after 15% tax)

$9,855.07/yr

After 10yr DRIP, annual income (after tax)

$2,308,358.49/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, EIGR beats the other by $2,306,077.96/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EIGR + RYLD for your $10,000?

EIGR: 50%RYLD: 50%

100% RYLD50/50100% EIGR

Portfolio after 10yr

$3.68M

Annual income

$1,359,199.43/yr

Blended yield

36.89%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EIGR right now

EIGR

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-24.5

Piotroski

4/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EIGR buys

RYLD buys

No recent congressional trades found for EIGR or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEIGRRYLD

Forward yield	115.94% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7.32M	$45.3K ✓
Annual income after 10y	$2,715,715.87 ✓	$2,682.98
Total dividends collected	$6.64M	$19.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EIGR vs RYLD ($10,000, DRIP)

Year	EIGR Portfolio	EIGR Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$22,294	$11,594.20	$11,939	$1,239.34	+$10.4K → EIGR
2	$48,012	$24,157.34	$14,158	$1,382.89	+$33.9K → EIGR
3	$99,994	$48,621.05	$16,682	$1,532.59	+$83.3K → EIGR
4	$201,631	$94,637.59	$19,537	$1,687.64	+$182.1K → EIGR
5	$394,091	$178,346.07	$22,752	$1,847.20	+$371.3K → EIGR
6	$747,454	$325,775.96	$26,355	$2,010.43	+$721.1K → EIGR
7	$1,377,237	$577,460.92	$30,376	$2,176.45	+$1.35M → EIGR
8	$2,468,047	$994,404.26	$34,847	$2,344.43	+$2.43M → EIGR
9	$4,306,232	$1,665,421.46	$39,800	$2,513.54	+$4.27M → EIGR
10	$7,323,384	$2,715,715.87	$45,269	$2,682.98	+$7.28M → EIGR

EIGR vs RYLD: Complete Analysis 2026

EIGR — Stock

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.

Full EIGR Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this EIGR vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EIGR vs SCHD EIGR vs JEPI EIGR vs O EIGR vs KO EIGR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.